Legal Representation
Attorney
Syed Abedi
USPTO Deadlines
Next Deadline
2068 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-18)
Due Date
March 18, 2031
Grace Period Ends
September 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 18, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Mar 18, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 28, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 28, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 22, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 25, 2024 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Oct 25, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 25, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 29, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Jul 29, 2024 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Jul 29, 2024 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Jul 29, 2024 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Jul 29, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 12, 2024 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Jul 12, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Apr 23, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 23, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jan 29, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jan 29, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jan 29, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Dec 23, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 22, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 22, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 3, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 3, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 3, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 29, 2023 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED | Loading... |
| Sep 28, 2023 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
| Sep 23, 2023 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
| Sep 23, 2023 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Sep 22, 2023 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED | Loading... |
| Sep 14, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 18, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 16, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 28, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Clinical preparations in the nature of RNA and genetic material, namely, plasmids, DNA, and chemically-modified RNA encoding RNA for use in the manufacture of medical preparations for treatment of genetic diseases
First Use Anywhere:
Aug 9, 2023
First Use in Commerce:
Aug 9, 2023
Class 005
Pharmaceutical preparations for the treatment of genetic diseases, namely, neurological diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases, namely, neurological diseases
First Use Anywhere:
Aug 9, 2023
First Use in Commerce:
Aug 9, 2023
Class 042
Development of pharmaceutical preparations and medicines for genetic diseases, namely, neurological diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases, namely, neurological diseases; none of the foregoing research services directed to providing a database comprising patient records to others in the fields of eyecare or ophthalmology
First Use Anywhere:
Jun 13, 2023
First Use in Commerce:
Jun 13, 2023
Additional Information
Design Mark
The mark consists of the stylized letters "IRIS" with a dashed arc shape appearing above the mark, connecting the two letter "I".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
042